UBS Group
ACH

UBS Group’s Accendra Health ACH Stock Holding History

UBS Group’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,300
Closed -$42K – 8073
2019
Q1 		$42K Hold
10,300
– – ﹤0.01% 5689
2018
Q4 		$65K Buy
+10,300
New +$107K ﹤0.01% 5883

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group's ACH Position: Q2 2026 in Review

UBS Group reduced its Accendra Health (ACH) stake by 69% in Q2 2026, selling an estimated $666K and leaving 94,395 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #6500.

UBS Group first reported a position in ACH in Q4 2014 and has held it in 47 quarters since. The position peaked at $6.99M in Q2 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • UBS Group held 94,395 shares of Accendra Health worth $323K as of Q2 2026.
  • UBS Group sold 214,339 Accendra Health shares in Q2 2026, an estimated $666K.
  • Accendra Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6500 holding.
  • UBS Group first reported a position in Accendra Health in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Accendra Health position peaked at $6.99M in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.